<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412020000900625</article-id>
<article-id pub-id-type="doi">10.24245/gom.v88i9.4081</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Carcinoma intraepitelial tubárico seroso como hallazgo posquirúrgico de endometriosis y útero miomatoso. Reporte de un caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Seuous tubal intraepithelial carcinoma as a post-surgical finding of endometriosis and myomatous uterus. A case report]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Luque-González]]></surname>
<given-names><![CDATA[Pablo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Requerey-Fernández]]></surname>
<given-names><![CDATA[Mercedes]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Frías-Sánchez]]></surname>
<given-names><![CDATA[Zoraida]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guadix-Martín]]></surname>
<given-names><![CDATA[María del Pilar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jiménez-Caraballo]]></surname>
<given-names><![CDATA[Antonio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gutiérrez-Domingo]]></surname>
<given-names><![CDATA[Álvaro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pantoja-Garrido]]></surname>
<given-names><![CDATA[Manuel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario Virgen Macarena Unidad de Gestión Clínica de Ginecología y Obstetricia ]]></institution>
<addr-line><![CDATA[Sevilla ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Universitario Virgen del Rocío Unidad de Gestión Clínica de Ginecología y Obstetricia ]]></institution>
<addr-line><![CDATA[Sevilla ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Universitario Virgen Macarena Unidad de Gestión Clínica de Anatomía Patológica ]]></institution>
<addr-line><![CDATA[Sevilla ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<volume>88</volume>
<numero>9</numero>
<fpage>625</fpage>
<lpage>631</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412020000900625&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412020000900625&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412020000900625&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  ANTECEDENTES: El carcinoma intraepitelial tubárico seroso es una lesión precursora del carcinoma invasivo de las trompas de Falopio que con frecuencia se diagnostica en el contexto de una salpingooforectomía bilateral profiláctica por patología ginecológica benigna.  CASO CLÍNICO:  Paciente nulípara, de 51 años, con cuadro clínico de dolor abdominal y elevación de marcadores tumorales CA-125 y CA-19.9, diagnosticada con útero polimiomatoso y sospecha de endometrioma en el ovario derecho. Después de la histerectomía subtotal con anexectomía bilateral, el estudio histológico de la pieza tubárica extirpada reportó focos microscópicos de carcinoma intraepitelial tubárico seroso, sin signos de invasión estromal. Por los hallazgos se solicitaron pruebas de imagen mamarias y el estudio genético de mutación BRCA 1 y 2.  CONCLUSIÓN: La salpingooforectomía bilateral profiláctica es un procedimiento que reduce el riesgo de carcinomas peritoneales, tubáricos y serosos de ovario. Las pacientes con carcinoma intraepitelial tubárico seroso deben tener seguimiento basado en controles ecográficos, pruebas de imagen mamarias, determinación de marcadores tumorales y estudios genéticos, debido a su asociación con mutaciones en los genes BRCA 1 y 2.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  BACKGROUND: Serous tubal intraepithelial carcinoma (STIC) is a precursor lesion of invasive high-grade tubal and serous carcinoma of the ovary, frequently diagnosed in the context of prophylactic bilateral salpingoophorectomy for benign gynecological pathology. The objective of this work is to carry out a literature review on the most relevant aspects of the follow-up of this injury, after its incidental diagnosis in gynecological surgery.  CLINICAL CASE:  A 51-year-old nulliparous patient who, in the context of a clinical situation of abdominal pain with elevation of tumor markers CA125 and CA19.9, was diagnosed with polymomatous uterus and suspected endometrioma in the right ovary. After a subtotal hysterectomy with bilateral adnexectomy, the histological study of the excised tubal specimen found microscopic foci of STIC without signs of stromal invasion. Given this finding, breast imaging tests and a genetic study of the BRCA 1/2 mutation was requested.  CONCLUSION: Prophylactic bilateral salpingoophorectomy in gynecological surgery is a procedure that can reduce the risk of developing peritoneal, tubal, and serous ovarian carcinomas. Patients diagnosed with STIC should be subsidiaries of follow-up based on ultrasound controls, mammary imaging tests, tumor markers, and genetic studies, due to their association in many cases with mutations in the BRCA 1/2 genes. It is necessary to establish a series of standardized clinical protocols for the management of patients with STIC and to continue advancing our understanding of this pathology and its subsequent evolution to high-grade serous carcinoma.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Carcinoma intraepitelial tubárico seroso]]></kwd>
<kwd lng="es"><![CDATA[ovario]]></kwd>
<kwd lng="es"><![CDATA[dolor abdominal]]></kwd>
<kwd lng="es"><![CDATA[marcadores tumorales]]></kwd>
<kwd lng="es"><![CDATA[endometrioma]]></kwd>
<kwd lng="es"><![CDATA[histerectomía subtotal]]></kwd>
<kwd lng="es"><![CDATA[mutación de los genes BRCA 1 y 2]]></kwd>
<kwd lng="es"><![CDATA[protocolos clínicos]]></kwd>
<kwd lng="en"><![CDATA[Serous tubal intraepithelial carcinoma]]></kwd>
<kwd lng="en"><![CDATA[Ovary]]></kwd>
<kwd lng="en"><![CDATA[Abdominal pain]]></kwd>
<kwd lng="en"><![CDATA[Tumor markers]]></kwd>
<kwd lng="en"><![CDATA[Endometrioma]]></kwd>
<kwd lng="en"><![CDATA[subtotal hysterectomy]]></kwd>
<kwd lng="en"><![CDATA[BRCA 1/2 mutations]]></kwd>
<kwd lng="en"><![CDATA[Clinical protocols]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutkin]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary]]></article-title>
<source><![CDATA[Cancer Biomark]]></source>
<year>2019</year>
<volume>26</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>471-9</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma]]></article-title>
<source><![CDATA[Nat Commun]]></source>
<year>2019</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>5367</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers]]></article-title>
<source><![CDATA[Gynecol Oncol Rep]]></source>
<year>2019</year>
<volume>28</volume>
<page-range>18-22</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stanciu]]></surname>
<given-names><![CDATA[PI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development of peritoneal carcinoma in women diagnosed with serous tubal intraepithelial carcinoma (STIC) following risk-reducing salpingo-oophorectomy (RRSO)]]></article-title>
<source><![CDATA[J Ovarian Res.]]></source>
<year>2019</year>
<volume>12</volume>
<page-range>50</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arora]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of SEE-FIM (Sectioning and Extensively Examining the FIMbriated End) protocol in identifying fallopian tube precursor lesions in women with ovarian tumors]]></article-title>
<source><![CDATA[J Obstet Gynaecol India]]></source>
<year>2019</year>
<volume>69</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>153-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaur]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Papillary syncytial metaplasia of fallopian tube endometriosis: a potential pitfall in the diagnosis of serous tubal intraepithelial carcinoma]]></article-title>
<source><![CDATA[Arch Pathol Lab Med]]></source>
<year>2013</year>
<volume>137</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>126-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seidman]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-grade pelvic serous carcinoma within the fallopian tube lumen: real or artifact?]]></article-title>
<source><![CDATA[Int J Gynecol Pathol]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rojo-Novo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Displasia epitelial tubárica de alto grado tras anexectomía bilateral profiláctica por cáncer de mama, en paciente con mutación en el gen BRCA1]]></article-title>
<source><![CDATA[Rev Obstet Ginecolog Venez]]></source>
<year>2018</year>
<volume>78</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>157-64</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meserve]]></surname>
<given-names><![CDATA[EEK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frequency of incidental serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study]]></article-title>
<source><![CDATA[Gynecol Oncol]]></source>
<year>2017</year>
<volume>146</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>69-73</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gilks]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas]]></article-title>
<source><![CDATA[Am J Surg Pathol]]></source>
<year>2015</year>
<volume>39</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>357-64</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Samimi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Population frequency of serous tubal intraepithelial carcinoma (STIC) in clinical practice using SEE-Fim Protocol]]></article-title>
<source><![CDATA[JNCI Cancer Spectrum]]></source>
<year>2018</year>
<volume>2</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Visvanathan]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fallopian tube lesions in women at high risk for ovarian cancer: a multicenter study]]></article-title>
<source><![CDATA[Cancer Prev Res (Phila)]]></source>
<year>2018</year>
<volume>11</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>697-706</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[JWH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Completeness of salpingectomy intended for ovarian cancer risk reduction]]></article-title>
<source><![CDATA[Gynecol Oncol]]></source>
<year>2019</year>
<volume>155</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>280-2</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
